Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to evaluate the efficacy and safety of KCT-0809 compared to placebo in patients with dry eye syndromes.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| KCT-0809 Lower Dose | Experimental |
| |
| KCT-0809 Higher Dose | Experimental |
| |
| Placebo | Placebo Comparator |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| KCT-0809 ophthalmic solution | Drug |
| ||
| Placebo |
| Measure | Description | Time Frame |
|---|---|---|
| Score of the Corneal conjunctival staining | 8weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Incidences of Adverse Events | 8weeks |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Tokyo and Other Japanese City | Japan |
Not provided
| ID | Term |
|---|---|
| D015352 | Dry Eye Syndromes |
| D003316 | Corneal Diseases |
| D003229 | Conjunctival Diseases |
| ID | Term |
|---|---|
| D007766 | Lacrimal Apparatus Diseases |
| D005128 | Eye Diseases |
Not provided
Not provided
| Drug |
|